To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Core Insights - The conference features the management team from Fiserv, including CEO Mike Lyons and new CFO Paul Todd [1] Group 1: Company Overview - The session will recap changes and insights from Mike Lyons regarding the company this year [2] - Discussions will include revenue decisions and new targets set by the company [2] Group 2: Segment Focus - The presentation will cover specifics on the two segments: Financial Solutions and Merchant Solutions [2] Group 3: Financial Strategy - The management will address financial aspects such as CapEx related to the One Fiserv initiative, divestitures, and capital allocation [2]

XLight to get up to $150 million to develop ultraprecise lasers for squeezing more circuits onto semiconductors ...

Key TakeawaysAmericans' household debt has climbed to a new record high, encompassing mortgages, car loans, credit cards, and student loans, according to the Federal Reserve Bank of New York.Samsung (SSNLF) unveiled its inaugural Galaxy Z Trifold phone, with plans for a US market launch in 2026.Australian shares saw gains, buoyed by firm metal prices, even as the nation reported a 6.4% month-over-month decline in October building approvals and a Q3 current account deficit widening to AUD 16.6 billion.HSBC p ...

These drugmakers are poised to profit from their innovative engines.Axsome Therapeutics (AXSM 1.63%) and Exelixis (EXEL 1.70%) are hardly the best-known players in the large biotech industry. Thankfully, they don't need to be so to have excellent prospects. Both of these relatively small drugmakers have a lot going on that could lead to excellent financial results and strong stock market performances in the medium term. Let's dig deeper into Axsome Therapeutics and Exelixis and discuss why both biotechs are ...

PresentationWelcome, everyone. This is the ProPhase Labs Webinar. We'll be getting started in 3 minutes at a quarter after the hour. This is the ProPhase Labs Webinar with RedChip. We'll be started.Operator Thank you very much. Let us get started. Hi. This is Craig with RedChip Companies. Thank you for joining today's event with ProPhase Labs, which trades on the NASDAQ under the ticker PRPH. With us today, we have Ted Karkus, the Chairman and CEO of ProPhase. We will begin with a brief presentation in a mo ...

Samsung Electronics unveiled on Tuesday its first multi-folding smartphone, in a bid to strengthen its position in a sector of the phone market where competition is expected to intensify. ...

How to Add Us to Google News Sending You to Google News in 3 © SDI Productions / E+ via Getty Images Skip to content S&P 500 6,818.20 -0.01% Dow Jones 47,274.60 -0.08% Nasdaq 100 25,373.60 +0.03% Russell 2000 2,475.97 +0.05% FTSE 100 9,690.40 -0.25% Nikkei 225 49,465.00 -0.03% Investing Two Sector ETFs Are Quietly Outperforming the S&P 500 Without a Single AI Stock Quick Read ByJohn Seetoo Just now This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation ...

Peshkova / Getty Images Subscribe Now: Apple Podcasts / Spotify / PlayerFM It may be a headline-driven market, but the charts and patterns inside the capital markets always tell the truth. We go inside the most important charts, patterns, and formations in technical analysis with Patrick Dunuwila of The Chart Report. Plus, the melt up in the stock market has also been accompanied by a big surge in implied volatility. What that tells us about the fragility of the stock market right now. Do you have a news t ...